Company profile
INFINITOPES
Infinitopes Limited is a UK company with status active founded in 2021 based in South East England.
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
Last confirmation statement made up date
Last accounts made up date
PSC08 | Transaction MzQ0MDk3MDM3MWFkaXF6a2N4
Published 25 Oct 2024 12:40
CS01 | Transaction MzQzOTE2NTUzNWFkaXF6a2N4
Published 11 Oct 2024 12:58
PSC07 | Transaction MzQzOTE2NTI2M2FkaXF6a2N4
Published 11 Oct 2024 12:40
PSC07 | Transaction MzQzOTE2NTIzNWFkaXF6a2N4
Published 11 Oct 2024 12:15
PSC07 | Transaction MzQzOTE2NTExOGFkaXF6a2N4
Published 11 Oct 2024 12:00
AA | Transaction MzQzNzY5MTUwOGFkaXF6a2N4
Published 30 Sep 2024 09:13
AP03 | Transaction MzQzMzEwMzg4MGFkaXF6a2N4
Published 22 Aug 2024 12:33
Company registered at Companies House
1 Dec 2023 to 31 Mar 2026
Infinitopes is a **Cancer Research UK (CRUK)-led spinout from Oxford University**. We are also backed by Cancer Research Institute NY, and leading British investors, Octopus Ventures, Kindred and Meltwind. Emerging from a decade of research excellence, we bring together **international scientific and medical leaders across oncology, immunology and vaccine...
1 Dec 2022 to 30 Nov 2025
Oesophageal cancer is the 5th cause of cancer death in the UK and prioritised as one of the four tumour types with the highest unmet clinical need according to Cancer Research UK. In particular, cancer metastases, or the spread of cancer to other critical body parts such as the liver, significantly reduces survival rates of patients. **_Therefore, early d...
